Capricor Therapeutics
CAPR
CAPR
177 hedge funds and large institutions have $1.03B invested in Capricor Therapeutics in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
34% more funds holding
Funds holding: 132 → 177 (+45)
30% more capital invested
Capital invested by funds: $791M → $1.03B (+$237M)
1.16% less ownership
Funds ownership: 59.98% → 58.82% (-1.2%)
Holders
177
Holding in Top 10
6
Calls
$119M
Puts
$52.8M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$45.3M | |
| 3 | +$36M | |
| 4 |
BlackRock
New York
|
+$15.2M |
| 5 |
Jane Street
New York
|
+$15.1M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$23.2M | |
| 3 | -$18.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.67M |
| 5 |
Millennium Management
New York
|
-$8.69M |
